CAM
IDXX icon

Chesapeake Asset Management’s Idexx Laboratories IDXX Stock Holding History

Chesapeake Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$419 – 420
2025
Q1 		$419 Buy
+1
New +$434 ﹤0.01% 455
2024
Q4 		– Sell
-1
Closed -$505 – 551
2024
Q3 		$505 Buy
+1
New +$486 ﹤0.01% 373

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chesapeake Asset Management's IDXX Position: Q2 2025 in Review

Chesapeake Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 1 share — an estimated $419 sold.

Chesapeake Asset Management first reported a position in IDXX in Q3 2024 and held it in 2 quarters. The position peaked at $505 in Q3 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Chesapeake Asset Management reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Chesapeake Asset Management sold 1 Idexx Laboratories share in Q2 2025, an estimated $419.
  • Chesapeake Asset Management first reported a position in Idexx Laboratories in Q3 2024 and held it in 2 quarters.
  • Chesapeake Asset Management's Idexx Laboratories position peaked at $505 in Q3 2024.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Chesapeake Asset Management's 13F filing for Q2 2025, filed 15 Oct 2025.